Chronic cough, defined as a cough persisting for more than eight weeks, is a common reason for medical consultations. Despite its prevalence, the diagnosis and management of this condition can be challenging due to its multifactorial etiology. This article aims to provide a comprehensive approach to diagnosing and managing chronic cough in clinical practice.
Chronic cough is often associated with common conditions such as gastroesophageal reflux disease (GERD), asthma, and upper airway cough syndrome (UACS). However, it can also be a symptom of more serious underlying conditions like lung cancer or pulmonary fibrosis. Understanding the pathophysiology of chronic cough is crucial for accurate diagnosis and effective treatment.
A systematic diagnostic approach is essential to identify the underlying cause of a chronic cough. This includes a thorough patient history, physical examination, and appropriate investigations such as chest radiographs, spirometry, and when indicated, bronchoscopy. Empirical treatment trials for GERD, asthma, and UACS may also be useful in some cases.
Management of chronic cough should be tailored according to the identified underlying cause. For instance, proton pump inhibitors may be prescribed for GERD-associated cough, while inhaled corticosteroids are often effective for asthma-related cough. Non-pharmacological interventions such as lifestyle modifications and speech therapy can also play a crucial role in managing this condition.
Chronic cough can significantly impact a patient's quality of life, underscoring the importance of a comprehensive approach to its diagnosis and management. A thorough understanding of its etiology, a systematic diagnostic approach, and tailored management strategies are key to improving patient outcomes. Continual research is necessary to further unravel the mystery of chronic cough and enhance our clinical practices.
1.
Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions
2.
Sevabertinib Approved for First-Line Mutated NSCLC
3.
After three years, responses to mounetuzumab in follicular lymphoma are still stable.
4.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
5.
AI can identify women at risk of breast cancer years in advance: Study
1.
Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy
2.
Pediatric Tumor Microenvironment Evolution: Mechanisms, Clinical Impact, and Therapeutic Implications
3.
Hematopoietic Stem Cell Activity Biomarkers in Aging
4.
Bone-Marrow Immune Cell Competition: Mechanisms, Clinical Implications, and Emerging Therapeutic Perspectives
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Emerging Concepts in Hematology
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation